NCT01577121View on ClinicalTrials.gov

Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Preterm Labor With Intact Membranes
Interventions
DRUG

indomethacin

50 mg / 6 hours during 5 days

DRUG

placebo

50 mg / 6 hours during 5 days

Trial Locations (1)

08028

Hospital Clinic of Barcelona- Maternity, Barcelona

All Listed Sponsors
lead

Sara Varea

OTHER

NCT01577121 - Evaluation of the Use of Indomethacin as Co-treatment in Women With Preterm Labor and High Risk of Intraamniotic Inflammation | Biotech Hunter | Biotech Hunter